## KMX: CarMax, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.57 indicates fundamental undervaluation. Caution: momentum weakening (-11.9% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($35.30)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 10)

**1. Labaton Keller Sucharow LLP Files Securities Class Action Against CarMax, Inc. and Certain of Its Executives**
- Source: Business Wire | 20251223T215311 | Bearish | Relevance: 100%
- Labaton Keller Sucharow LLP has filed a securities class action lawsuit against CarMax, Inc. and certain executives on behalf of the Indiana Public Retirement System. The lawsuit alleges that CarMax misled investors by failing to disclose underperforming loans, inadequate loss reserves, an oversupply of vehicles leading to depreciation, and that sales boosts were due to temporary market conditions. Investors who purchased CarMax securities between June 20, 2025, and November 5, 2025, are encouraged to seek appointment as Lead Plaintiff by January 2, 2026.

**2. KMX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that CarMax, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit**
- Source: GlobeNewswire | 20251223T170804 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against CarMax, Inc. (NYSE: KMX) on behalf of investors who purchased securities between June 20, 2025, and November 5, 2025. The lawsuit alleges that CarMax overstated its growth prospects, which were temporarily boosted by tariffs, leading to investor damages. Investors who suffered losses have until January 2, 2026, to request to be appointed as lead plaintiff.

**3. CARMAX INC SEC 10-Q Report**
- Source: TradingView â€” Track All Markets | 20251223T150818 | Bearish | Relevance: 100%
- CarMax Inc. (KMX) has released its Form 10-Q report for the third quarter of fiscal 2026, revealing challenging financial and operational metrics. The company experienced declines in net sales, gross profit, and net earnings, with net earnings per diluted share falling to $0.43. Despite these setbacks, CarMax continues to focus on strengthening its omni-channel capabilities, expanding its customer base, and leveraging its physical and digital infrastructure.

**4. Levi & Korsinsky Reminds CarMax, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 2, 2026 - KMX**
- Source: KWKT - FOX 44 | 20251223T140803 | Bearish | Relevance: 100%
- Levi & Korsinsky, LLP has reminded investors of CarMax, Inc. (NYSE: KMX) about a pending class action lawsuit. Investors who allegedly suffered losses due to securities fraud between June 20, 2025, and November 5, 2025, have until January 2, 2026, to request appointment as lead plaintiff. The lawsuit claims CarMax overstated growth prospects, suggesting early fiscal year 2026 growth was a temporary benefit from tariff speculation rather than sustainable business operations.

**5. KMX INVESTORS: CarMax, Inc. Stock Drops 24% after CEO**
- Source: GlobeNewswire | 20251223T130848 | Bearish | Relevance: 100%
- A class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and its executives for securities fraud following a significant stock drop. The lawsuit alleges that the company misrepresented demand for its cars, and that unexpected CEO departure contributed to further stock declines. Investors have until January 2, 2026, to apply to lead the case.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 4, Lowers: 5)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Barclays | $24 | $28 | -14% |
| 2025-12-19 | Truist Securiti | $37 | $35 | +6% |
| 2025-12-19 | B of A Securiti | $31 | $27 | +15% |
| 2025-12-19 | JP Morgan | $28 | $30 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Barclays | main | Underweight |
| 2025-12-19 | Truist Securiti | main | Hold |
| 2025-12-19 | B of A Securiti | main | Underperform |
| 2025-12-19 | JP Morgan | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.59M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (-3.8%)
- Blackrock Inc.: 7.8% (+5.9%)
- State Street Corpora: 3.8% (-2.2%)
- Janus Henderson Grou: 3.3% (+1.0%)
- Diamond Hill Capital: 3.3% (-30.6%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-11.9% 5d) with bearish MACD, trend may be turning.
2. Elevated short interest (11.8%): bears positioning against stock.
3. Long-term trend broken: trading 32.8% below SMA200.
4. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Analyst target momentum: 4 raises (avg +9%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.57 indicates undervaluation relative to growth. Balance sheet: $1.1B free cash flow. Analyst sentiment negative (5 target cuts vs 4 raises). Insider buying signal ($0.6M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.5B |
| Beta | 1.29 |
| 52W Range | $30.26 - $89.47 |
| Short Interest | 11.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.57 |
| Forward P/E | 14.9 |
| Current P/E | 14.4 |
| YoY Growth | -3.2% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 8.6% to -3.3% (-11.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.3pp (needs >4.0% for momentum thesis). Underperforming sector by 4.4pp, stock-specific weakness. Below SMA200 (0.67x), long-term trend not supportive. RSI neutral at 46. Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.32% (CS: 21) | Weak |
| RSI_14 | 46.1 | Neutral |
| MACD Histogram | -0.07 | Bearish |
| vs SMA20 | 0.977x | Below |
| vs SMA50 | 0.982x | Below |
| vs SMA200 | 0.672x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $38.46
- **Stop Loss:** $35.30 (8.2% risk)
- **Target:** $44.78 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 284
- **Position Value:** $10,922.64
- **Portfolio %:** 10.92%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.32 | $0.43 | +36.1% |
| 2025Q3 | $1.04 | $0.64 | -38.6% |
| 2025Q2 | $1.17 | $1.38 | +18.3% |
| 2025Q1 | $0.66 | $0.58 | -12.3% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*